gip/glp 1-agonist tirzepatide Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Tirzepatide's Unique Mechanism of Action
Description
The role of pancreatic preproglucagon in glucose homeostasis in mice
While rare complications like gastroparesis (stomach paralysis) or pancreatitis can occur, they are uncommon
Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125
Anchor therapy Zepbound established an approved treatment pathway in chronic weight management
The results of our meta-analysis are in concordance with the previous reviews regarding the anthropometric, metabolic, and hormonal outcomes
